SCHEMBL5663162

SCHEMBL5663162

O=C(O)Cc1cccc(-c2ccsc2)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRMT6 Q96LA8 1/20 0.56
GRIN2D O15399 1/20 0.51
GRIN3B O60391 1/20 0.51
GRIN1 Q05586 1/20 0.51
GRIN2A Q12879 1/20 0.51
GRIN2B Q13224 1/20 0.51
GRIN2C Q14957 1/20 0.51
GRIN3A Q8TCU5 1/20 0.51
CYP2E1 P05181 1/20 0.48
CYP2A6 P11509 1/20 0.48
CYP2B6 P20813 1/20 0.48
PTGS2 P35354 1/20 0.48
ENPP2 Q13822 1/20 0.47
ACMSD Q8TDX5 1/20 0.46
AKR1B1 P15121 1/20 0.46
CNR1 P21554 1/20 0.45
ABCC4 O15439 1/20 0.44
LMNA P02545 1/20 0.44
GAA P10253 1/20 0.44
TSHR P16473 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9253589 0.86 PRMT6 (0.55) PRMT6GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL9253593 0.84 PRMT6 (0.56) PRMT6CYP2E1CYP2A6CYP2B6ACMSD
SCHEMBL28032595 0.82 LMNA (0.63) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL538397 0.81 ABCC4 (0.67) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL9454377 0.80 PRMT6 (0.63) PRMT6CYP2E1CYP2A6CYP2B6ENPP2
SCHEMBL1083457 0.80 ABCC4 (0.60) CYP2E1CYP2A6CYP2B6ACMSDAKR1B1
Methyl Alcohol SCHEMBL7855784 0.78 ABCC4 (0.62) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL7030142 0.78 ACMSD (0.58) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL9251496 0.78 ABCC4 (0.74) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL3936298 0.77 PRKCI (0.64) PRMT6GRIN2DGRIN3BGRIN1GRIN2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1471923-A4 AMIDO MACROLIDES KOSAN BIOSCIENCES INC (US) 2006-01-11 EP disclosed
US-6939861-B2 Amido macrolides KOSAN BIOSCIENCES, INC. (US) 2005-09-06 US disclosed
EP-1471923-A1 AMIDO MACROLIDES Kosan Biosciences, Inc. (US) 2004-11-03 EP disclosed
US-20030199458-A1 Amido macrolides KOSAN BIOSCIENCES, INC. 2003-10-23 US disclosed
WO-2003061671-A1 AMIDO MACROLIDES KOSAN BIOSCIENCES, INC. (US) 2003-07-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030199458-A1 Amido macrolides PCSK9, ABCB4, PCSK7 PRMT6 3021/4885GRIN2D 4340/4885GRIN3B 4231/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.